Sputnik V vaccine receives authorization in India
Singapore, April 13 -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces that Drug Controller General of India (DCGI) has approved the use of the Russian Sputnik V vaccine against coronavirus in the country. India has become the 60th country to approve Sputnik V.
Sputnik V is one of only three coronavirus vaccines registered by India's regulatory authorities.
India is the most populated country to register the Russian vaccine. Total population of 60 countries where Sputnik V is approved for use is 3 billion people or about 40% of the global population.
The vaccine has been registered in India under the emergency use authorization procedure based on results of clinical trials in Russia as well as positi...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.